ResMed Inc. (RMD)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| History | Portfolio Manager | Activity ▲ | Share change | % change to portfolio | |
| Q1 2024 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 1,909 | 0.01 | |
| Q3 2023 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 58.96% | 2,185 | 0.01 | |
| Q2 2023 | |||||
| ≡ | Jensen Investment Management | Add 17.51% | 3,440 | 0.01 | |
| ≡ | Lee Ainslie - Maverick Capital | Add 159.34% | 2,277 | 0.01 | |
| Q1 2023 | |||||
| ≡ | Jensen Investment Management | Add 12.48% | 2,180 | 0.00 | |
| ≡ | Lee Ainslie - Maverick Capital | Buy | 1,429 | 0.01 | |
| Q2 2022 | |||||
| ≡ | Jensen Investment Management | Add 17.37% | 2,700 | 0.00 | |
| Q1 2022 | |||||
| ≡ | Jensen Investment Management | Add 95.23% | 7,580 | 0.01 | |
| Q4 2021 | |||||
| ≡ | Jensen Investment Management | Buy | 7,960 | 0.01 | |
| Q4 2020 | |||||
| ≡ | AKO Capital | Buy | 356,305 | 0.98 | |
| Q3 2020 | |||||
| ≡ | Francois Rochon - Giverny Capital | Buy | 437 | 0.01 | |
| Q3 2019 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 57,354 | 0.11 | |
| Q2 2018 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 48,810 | 0.06 | |
| Q3 2008 | |||||
| ≡ | Bill & Melinda Gates Foundation Trust | Buy | 43,906 | 0.01 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.